Stocky turns companies like PHOENIXBIO CO LTD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Avoid. 6190.T scores poorly across all fundamental dimensions—Growth Compounder (9/100) and Value Compounder (20/100) signal neither profitable growth nor attractive valuation, while Leadership Alignment (36.3/100) suggests misalignment between insiders and shareholders. The business lacks the earnings power or growth trajectory to justify ownership at current risk.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for PHOENIXBIO CO LTD:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 38/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates PHOENIXBIO CO LTD (6190.T) at 38/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. 6190.T scores poorly across all fundamental dimensions—Growth Compounder (9/100) and Value Compounder (20/100) signal neither profitable growth nor attractive valuation, while Leadership Alignment (36.3/100) suggests misalignment bet
6190.T's current Stocky Verdict is 38/100, placing it in the "Avoid" band. This composite combines a 20/100 Compounder score, 36/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for PHOENIXBIO CO LTD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
PHOENIXBIO CO LTD scores 36/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
PHOENIXBIO CO LTD's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to PHOENIXBIO CO LTD.
Sign up free and unlock the full analysis on 6190.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 6190.T in the app.
